France Amniocentesis Needle Market Insight
Published: 04 June 2026 | Report Format: Electronic (PDF)
The France Amniocentesis Needle Market will grow at a rate of 6.7%% due to advanced maternal age, prevalence of genetic disorders, healthcare guidelines and access, technological advancements.
France Amniocentesis Needle Market Insights Forecasts to 2035
- The France Amniocentesis Needle Market Size Was Estimated USD 6.7% Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.7%from 2025 to 2035
- The France Amniocentesis Needle Market is Expected to rise around USD 11.82 Million by 2035
Notable Insights for the France Amniocentesis Needle Market
- Segmentation on the basis of Type indicates that due to its adaptability, ideal procedure depth, and wide clinical relevance, the 100–150 mm sector has a nearly 53% market share in France for amniocentesis needles in 2025.
- Segmentation on the basis of Procedure indicates that due to its gold-standard diagnostic accuracy and growing maternal age, the amniocentesis segment leads the French amniocentesis needle market in 2025 with a nearly 61.7% share.
- In France, medically indicated amniocentesis procedures receive up to 100% reimbursement under national health insurance, supporting over 95% prenatal diagnostic access for high-risk pregnancies.
- Mutuelle coverage is held by more than 95% of French individuals, which lowers out-of-pocket costs and improves financial access to prenatal diagnostics and specialised pregnancy care services.
Download the eBook (ToC)
Why Buy This Report
- This report offers market size, growth projections, competitor analysis and key trends, thus assisting stakeholders to discover growth opportunities and make investments appropriately.
- With the segmentation based on needle length, procedure type, end user and application, the report presents a detailed market insight for manufacturers, distributors, and health care providers for demand estimation and market strategies.
- The report identifies market drivers, technology development, reimbursement systems, and policy regulations, and provides specific insights for product development, market entry and business expansion strategies.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France Amniocentesis Needle Market along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in France Amniocentesis Needle Market
Laboratoire CCD
CooperSurgical
Cook Medical
Becton Dickinson (BD)
Medtronic
Integra LifeSciences
RI.MOS
Rocket Medical
Biopsybell
Medline Industries, LP.
Recent Developments:
- In July 2025, Cook Medical established a dedicated iMRI division to advance MRI-guided needle interventions. The initiative builds on more than 30 years of MRI-compatible needle expertise, enhancing accuracy and reducing radiation exposure during image-guided procedures.
- In April 2025, Cook Medical established a dedicated iMRI division to advance MRI-guided needle interventions. The initiative builds on more than 30 years of MRI-compatible needle expertise, enhancing accuracy and reducing radiation exposure during image-guided procedures.
Market Segmentation:
France Amniocentesis Needle Market, By Product Type
- 100-150mm
- Larger than 150mm
- Smaller than 100mm
France Amniocentesis Needle Market, By Procedure
- Amniocentesis
- Amnioreduction
- Fetal Blood Transfusion
- Amnioinfusion
- Cordocentesis
France Amniocentesis Needle Market, By Application
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Chemical & Pharmaceutical Testing
Expert Views:
France Amniocentesis Needle Market is expected to grow at a stable rate till 2035, with driving factors like increasing maternal age, growth in demand for prenatal genetic testing, supportive reimbursement policies, and rapid innovations in fetal diagnostics. Development of sound healthcare infrastructure, wide availability of health insurance cover, and increased consciousness for early detection of genetic disorders are expected to fuel the market growth. The long prevalence of standard-length needles and amniocentesis procedures in France indicates the critical need for safe, accurate, and clinically proven diagnostic solutions.
Author: Govind and Krishna By Spherical Insights and Consulting